News
Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...
Exo has obtained 510(k) clearance for two AI-based apps that detect two common lung conditions with its Exo Iris POCUS device ...
GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, ...
NHS England chair Penny Dash shared her views on European healthcare during a fireside discussion at HLTH Europe in Amsterdam ...
MedTech Europe has issued a statement calling on European policymakers to exempt medical technologies from any trade tariffs ...
Visby Medical has secured around $55m in its funding round to expedite the launch and distribution of its at-home Women's ...
Philips has launched a new point-of-care (POC) ultrasound system designed to broaden the accessibility of ultrasound for ...
Brain Navi Biotechnology’s stereotaxic guiding surgical device, NaoTrac, has gained 510(k) clearance from the FDA.
Johnson & Johnson has introduced the TECNIS Odyssey IOL in the Middle East, Canada, and Europe, widening its range of PC-IOLs ...
Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...
The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.
Penumbra has completed subject enrolment in the multi-centre, randomised controlled trial, STORM-PE, for pulmonary embolism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results